X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Morris Christopher Daniel | CEO | A - Grant | $0.00 | +9,077 | 70,101 | +15% | +$0 | |||||
D | 2024-04-24 | LGND | Ligand Pharmaceuticals Inc | Kozarich John W | Dir | M - OptEx | $39.35 | +2,893 | 42,523 | +7% | +$113,840 | |||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Mulleady John | SVP, RE, Dev | A - Grant | $0.00 | +1,643 | 58,363 | +3% | +$0 | |||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Wehner Tony | SVP, COO | A - Grant | $0.00 | +1,633 | 33,670 | +5% | +$0 | |||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Pineiro Antonio | SVP, Chief Int'l Dev Ofc | A - Grant | $0.00 | +1,292 | 25,376 | +5% | +$0 | |||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Klohn Steve | SVP CIO | A - Grant | $0.00 | +1,210 | 32,169 | +4% | +$0 | |||||
2024-04-26 | RCL | Royal Caribbean Cruises Ltd | Liberty Jason T | Pres, CEO | S - Sale | $139.63 | -50,000 | 153,017 | -25% | -$6,981,335 | ||||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Estrada Megan | CMO | A - Grant | $0.00 | +1,172 | 14,391 | +9% | +$0 | |||||
D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Lehner Les | SVP, Chief Procurement Ofc | A - Grant | $0.00 | +1,134 | 30,001 | +4% | +$0 | |||||
D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | $144.69 | +5,500 | 8,663 | +174% | +$795,795 | |||||
D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | D - Sale to issuer | $270.95 | -2,938 | 8,663 | -25% | -$796,051 | |||||
D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | S - Sale+OE | $269.35 | -2,562 | 8,663 | -23% | -$690,080 | |||||
2024-04-25 | GOOG | Alphabet Inc. | O'Toole Amie Thuener | VP, Chief Accounting Officer | C - Converted deriv | $0.00 | 2,728 | 91,428 | -3% | $0 | ||||||
2024-04-25 | GOOG | Alphabet Inc. | O'Toole Amie Thuener | VP, Chief Accounting Officer | F - Tax | $161.10 | -1,391 | 91,428 | -1% | -$224,090 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Blackwell Jean S | Dir | A - Grant | $0.00 | +2,800 | 20,302 | +16% | +$0 | ||||||
AM | 2024-04-17 | BFYW | Better For You Wellness, Inc. | James Ian Andrew | CEO, 10% | A - Grant | $0.00 | +60,000 | 56,056,849 | 0% | +$139 | |||||
2024-04-24 | CONN | Conns Inc | Martin Douglas H | Dir, 10% | P - Purchase | $3.74 | +1,000 | 226,153 | 0% | +$3,740 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Fernandez-Moreno Luis M | Dir | A - Grant | $0.00 | +2,800 | 22,352 | +14% | +$0 | ||||||
2024-04-24 | ROII | Riskon International, Inc. | Ault Milton C III | CEO | P - Purchase | $0.02 | +43,147 | 893,492 | +5% | +$867 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Gulyas Diane H. | Dir | A - Grant | $0.00 | +2,800 | 12,574 | +29% | +$0 | ||||||
2024-04-24 | NYT.A | New York Times Co | Tishler Margot Golden | Dir | A - Grant | $0.00 | +4,048 | 1,461,368 | 0% | +$0 | ||||||
2024-04-25 | TEAM | Atlassian Corp | Cannon-Brookes Michael | Co-CEO, Co-Founder, 10% | S - Sale | $197.53 | -8,241 | 358,209 | -2% | -$1,627,835 | ||||||
2024-04-25 | TEAM | Atlassian Corp | Farquhar Scott | Co-CEO, Co-Founder, 10% | S - Sale | $197.53 | -8,241 | 358,209 | -2% | -$1,627,835 | ||||||
2024-04-24 | NYT.A | New York Times Co | Golden Arthur S. | Dir | A - Grant | $0.00 | +4,048 | 1,528,163 | 0% | +$0 | ||||||
2024-04-25 | BTSG | Brightspring Health Services, Inc. | Rousseau Jon B | See Remarks | F - Tax | $10.41 | -36,740 | 1,358,659 | -3% | -$382,463 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Hoechner Bruce D. | Dir | A - Grant | $0.00 | +2,800 | 4,771 | +142% | +$0 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Zuber Maria T | Dir | A - Grant | $0.00 | +7,045 | 60,434 | +13% | +$0 | ||||||
2024-04-25 | RKT | Rocket Companies, Inc. | Rizik Matthew | Dir | P - Purchase | $12.07 | +349 | 698,204 | 0% | +$4,212 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Woods Thomas D | Dir | A - Grant | $0.00 | +7,045 | 118,460 | +6% | +$0 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Woods Thomas D | Dir | F - Tax | $38.32 | -3,249 | 118,460 | -3% | -$124,502 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Lynch Frederick J | Dir | A - Grant | $0.00 | +2,800 | 22,302 | +14% | +$0 | ||||||
2024-04-24 | FPH | Five Point Holdings, LLC | Luxor Capital Group, LP | 10% | S - Sale | $2.99 | -11,796 | 10,372,787 | 0% | -$35,300 | ||||||
D | 2024-04-24 | TALK | Talkspace, Inc. | Dziedzic Steven | Chief Product Officer | M - OptEx | $0.88 | +11,574 | 359,035 | +3% | +$10,185 | |||||
2024-04-22 | DGX | Quest Diagnostics Inc | Gregg Vicky B | Dir | A - Grant | $126.24 | +81 | 16,410 | 0% | +$10,226 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | A - Grant | $126.25 | +45 | 17,104 | 0% | +$5,681 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $126.25 | +69 | 16,062 | 0% | +$8,711 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Samad Sam | EVP, CFO | A - Grant | $126.25 | +24 | 21,356 | 0% | +$3,030 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Narwold Karen G | Dir | A - Grant | $0.00 | +2,800 | 12,939 | +28% | +$0 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Sansone Daniel F | Dir | A - Grant | $0.00 | +2,800 | 19,649 | +17% | +$0 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Wright Benjamin G. | Dir | A - Grant | $0.00 | +2,800 | 5,987 | +88% | +$0 | ||||||
D | 2024-04-25 | MAIA | Maia Biotechnology, Inc. | Louie Ngar Yee | Dir | P - Purchase | $2.03 | +19,665 | 1,167,189 | +2% | +$39,920 | |||||
2024-04-24 | FHB | First Hawaiian, Inc. | Washington Vanessa L | Dir | A - Grant | $0.00 | +3,151 | 16,638 | +23% | +$0 | ||||||
D | 2024-04-25 | MAIA | Maia Biotechnology, Inc. | Smith Stan | Dir | P - Purchase | $2.03 | +147,492 | 1,005,060 | +17% | +$299,409 | |||||
2024-04-24 | FHB | First Hawaiian, Inc. | Uyeda Allen Bruce | Dir | A - Grant | $0.00 | +3,151 | 29,133 | +12% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Thompson Kelly Ann | Dir | A - Grant | $0.00 | +3,151 | 11,236 | +39% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Mugiishi Mark M | Dir | A - Grant | $0.00 | +3,151 | 7,956 | +66% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Moffatt Jim | Dir | A - Grant | $0.00 | +3,151 | 11,236 | +39% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Kurren Faye W | Dir | A - Grant | $0.00 | +3,151 | 25,418 | +14% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Fujimoto Michael K | Dir | A - Grant | $0.00 | +3,151 | 12,645 | +33% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Wo Craig Scott | Dir | A - Grant | $0.00 | +3,151 | 70,190 | +5% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Van Dyck Rebecca | Dir | A - Grant | $0.00 | +4,048 | 49,820 | +9% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Subramanian Anuradha B. | Dir | A - Grant | $0.00 | +4,048 | 5,865 | +223% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Rogers John W Jr | Dir | A - Grant | $0.00 | +4,048 | 47,966 | +9% | +$0 | ||||||
D | 2024-04-25 | WLY | John Wiley & Sons, Inc. | Dobson David C | Dir | A - Grant | $38.13 | +122 | 13,390 | +1% | +$4,652 | |||||
2024-04-24 | IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | S - Sale | $28.90 | -3,261 | 141,616 | -2% | -$94,243 | ||||||
D | 2024-04-24 | NYT | New York Times Co | McAndrews Brian P | Dir | A - Grant | $0.00 | +4,048 | 52,980 | +8% | +$0 | |||||
2024-04-24 | BAC | Bank of America Corp /de/ | Donald Arnold W | Dir | A - Grant | $0.00 | +7,045 | 118,533 | +6% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Glaser Rachel C | Dir | A - Grant | $0.00 | +4,048 | 29,223 | +16% | +$0 | ||||||
2024-04-24 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $28.90 | -7,239 | 147,739 | -5% | -$209,207 | ||||||
D | 2024-04-24 | SCHW | Schwab Charles Corp | Crawford Peter B. | CFO | M - OptEx | $28.44 | +5,481 | 60,567 | +10% | +$155,880 | |||||
D | 2024-04-24 | SCHW | Schwab Charles Corp | Crawford Peter B. | CFO | S - Sale+OE | $75.51 | -5,481 | 60,567 | -8% | -$413,855 | |||||
2024-04-24 | LCID | Lucid Group, Inc. | Alnowaiser Turqi A. | Dir, 10% | F - Tax | $2.52 | -4,432 | 2,117,804 | 0% | -$11,169 | ||||||
2024-04-24 | NYT | New York Times Co | Brooke Beth A. | Dir | A - Grant | $0.00 | +4,048 | 15,842 | +34% | +$0 | ||||||
2024-04-24 | LCID | Lucid Group, Inc. | Nouri Chabi | Dir | F - Tax | $2.52 | -2,344 | 46,043 | -5% | -$5,907 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | De Weck Pierre J.P. | Dir | A - Grant | $0.00 | +7,045 | 95,169 | +8% | +$0 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | De Weck Pierre J.P. | Dir | F - Tax | $38.32 | -1,405 | 95,169 | -1% | -$53,840 | ||||||
2024-04-24 | NYT | New York Times Co | Bronstein Manuel | Dir | A - Grant | $0.00 | +4,048 | 14,126 | +40% | +$0 | ||||||
2024-04-24 | IMVT | Immunovant, Inc. | Levine Mark S. | GC | S - Sale | $28.90 | -3,963 | 343,156 | -1% | -$114,531 | ||||||
M | 2024-04-24 | STCN | Steel Connect, Inc. | Steel Partners Holdings L.P. | Dir, 10% | P - Purchase | $12.00 | +265,326 | 3,026,570 | +10% | +$3,183,244 | |||||
2024-04-24 | NYT | New York Times Co | Bhutani Amanpal Singh | Dir | A - Grant | $0.00 | +4,048 | 25,579 | +19% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Chambers James P. | Dir | A - Grant | $0.00 | +2,723 | 12,216 | +29% | +$0 | ||||||
2024-04-24 | LASAX | Lord Abbett Special Situations Income Fund | Lord, Abbett & Co. LLC | Investment Adviser | S - Sale | $9.30 | -340,916 | 0 | -100% | -$3,170,521 | ||||||
2024-04-24 | MPLN | Multiplan Corp | Klein Michael Stuart | Dir | A - Grant | $0.00 | +172,413 | 23,166,492 | +1% | +$0 | ||||||
2024-04-24 | LCRDX | Lord Abbett Credit Opportunities Fund | Kewjin Yuoh | Portfolio Manager | D - Sale to issuer | $8.87 | -3,382 | 2,888 | -54% | -$30,000 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Almeida Jose E | Dir | A - Grant | $0.00 | +7,045 | 20,935 | +51% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Wiseman Eric C | Dir | A - Grant | $0.00 | +539 | 22,520 | +2% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Ozuah Philip | Dir | A - Grant | $0.00 | +539 | 1,163 | +86% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | McClellan Mark B. | Dir | A - Grant | $0.00 | +539 | 5,471 | +11% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Kurian George | Dir | A - Grant | $0.00 | +539 | 3,140 | +21% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Zarcone Donna F | Dir | A - Grant | $0.00 | +539 | 26,097 | +2% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Ross Kimberly A. | Dir | A - Grant | $0.00 | +539 | 3,874 | +16% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Mazzarella Kathleen M | Dir | A - Grant | $0.00 | +539 | 5,471 | +11% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Hathi Neesha | Dir | A - Grant | $0.00 | +539 | 2,731 | +25% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Granger Elder | Dir | A - Grant | $0.00 | +539 | 5,471 | +11% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Foss Eric J | Dir | A - Grant | $0.00 | +539 | 35,276 | +2% | +$0 | ||||||
2024-04-24 | CI | Cigna Group | Delaney William J III | Dir | A - Grant | $0.00 | +539 | 17,539 | +3% | +$0 | ||||||
2024-04-24 | ENSG | Ensign Group, Inc | Christensen Christopher R. | Exec COB | W - Inherited | $0.00 | 7,219 | 1,184,232 | -1% | $0 | ||||||
D | 2024-04-24 | SQ | Block, Inc. | Grassadonia Brian | Cash App Lead | A - Grant | $0.00 | +86,903 | 564,193 | +18% | +$0 | |||||
D | 2024-04-24 | SQ | Block, Inc. | Esperanza Chrysty | Counsel Lead | A - Grant | $0.00 | +33,425 | 94,118 | +55% | +$0 | |||||
2024-04-24 | SQ | Block, Inc. | Dale Ajmere | Chief Accounting Officer | A - Grant | $0.00 | +26,740 | 94,171 | +40% | +$0 | ||||||
D | 2024-04-24 | SQ | Block, Inc. | Ahuja Amrita | CFO, COO | A - Grant | $0.00 | +100,273 | 289,674 | +53% | +$0 | |||||
2024-04-25 | OB | Outbrain Inc. | Zagorski Mark | Dir | A - Grant | $0.00 | +30,000 | 32,500 | >999% | +$0 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Czaja Mark T | VP, Chief Tech., Info Officer | A - Grant | $0.00 | +2,922 | 5,627 | +108% | +$0 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Czaja Mark T | VP, Chief Tech., Info Officer | F - Tax | $546.35 | -1,040 | 5,627 | -16% | -$568,204 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Bendali Rachid | VP, Pres- Eng. Mat. Grp. | A - Grant | $0.00 | +1,980 | 3,257 | +155% | +$0 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Bendali Rachid | VP, Pres- Eng. Mat. Grp. | F - Tax | $546.35 | -736 | 3,257 | -18% | -$402,114 | ||||||
D | 2024-04-25 | ISRG | Intuitive Surgical Inc | Johnson Amal M | Dir | M - OptEx | $0.00 | +569 | 12,275 | +5% | +$0 | |||||
2024-04-24 | NARI | Inari Medical, Inc. | Warner Robert Keith | Dir | A - Grant | $42.41 | +4,126 | 12,149 | +51% | +$174,984 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Hart Mark J | EVP-HR, External Affairs | A - Grant | $0.00 | +3,732 | 10,149 | +58% | +$0 | ||||||
2024-04-24 | PH | Parker Hannifin Corp | Hart Mark J | EVP-HR, External Affairs | F - Tax | $546.35 | -1,674 | 10,149 | -14% | -$914,590 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |